Athanor Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,024
Closed -$310K 822
2020
Q4
$310K Buy
+2,024
New +$310K 0.01% 525
2020
Q3
Sell
-2,746
Closed -$202K 540
2020
Q2
$202K Buy
+2,746
New +$202K 0.01% 483
2020
Q1
Sell
-5,910
Closed -$360K 180
2019
Q4
$360K Buy
+5,910
New +$360K 0.02% 250